Resilience and Late-Life Depression: Clinical features; Biomarkers; and Interventions
Thursday, September 2 at 6 PM Eastern
Date of CE Release: 09/02/2021
Date of CE Expiration: 09/02/2022
Helen Lavretsky, MD, MS
Julie Dumas, PhDUniversity of Vermont Health Network
Summary: Psychological resilience has been broadly defined as “the capacity to maintain, or regain, psychological well-being in the face of challenge” Resilience is a complex construct that can be conceptualized as an attribute (a trait) that is possessed to varying degrees by different individuals, a dynamic process (a state) with bidirectional relations to developmental and environmental factors, and as an outcome in the face of stress and adversity. Few studies have investigated resilience in depression, and even fewer have examined resilience in depressed older adults and as a target for novel interventions to treat depression. In this presentation, clinical features of resilience relevant for depression outcomes will be discussed. The biomarkers of resilience will be presented. Approaches to using mind-body and antidepressant interventions boosting psychological and cognitive resilience will be highlighted.
Activity Type: Knowledge Based
Objectives for Webinar:
2. Describe biomarkers of psychological resilience
3. Resilience as predictor of response to antidepressant treatment
4. Resilience-enhancing Mind-body and pharmacological therapies that improve clinical outcomes of late life depression
Acknowledgement of Support
This webinar is supported in part by an unrestricted educational grant provided by the American Board of Psychiatry and Neurology (ABPN).
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and American Association for Geriatric Psychiatry. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Amedco LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Amedco LLC designates this activity for a maximum of1.0 ANCC contact hours.
Amedco LLC designates this activity for a maximum of 1.0 knowledge-based CPE contact hours.
Amedco LLC designates this activity for a maximum of 1.0 psychologist contact hours.
As a Jointly Accredited Organization, Amedco is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Amedco maintains responsibility for this course. Social workers completing this course receive 1.0 GENERAL continuing education credits.
Disclosure of Relevant Financial Relationships:
The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-‐6.2, 6.5)
All individuals in a position to control the content of CE are listed in the program book. If their name is not listed below, they disclosed that they had no relevant financial relationships.
|Helen Lavretsky||No relevant financial relationship exists|
|Julie Dumas||No relevant financial relationship exists|